Growth Metrics

GeneDx Holdings (WGS) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $87.6 million.

  • GeneDx Holdings' Total Current Liabilities rose 1329.03% to $87.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.6 million, marking a year-over-year increase of 1329.03%. This contributed to the annual value of $54.8 million for FY2024, which is 680.23% down from last year.
  • Latest data reveals that GeneDx Holdings reported Total Current Liabilities of $87.6 million as of Q3 2025, which was up 1329.03% from $71.4 million recorded in Q2 2025.
  • GeneDx Holdings' Total Current Liabilities' 5-year high stood at $204.6 million during Q2 2022, with a 5-year trough of $50.7 million in Q1 2024.
  • Its 5-year average for Total Current Liabilities is $91.4 million, with a median of $72.6 million in 2021.
  • Per our database at Business Quant, GeneDx Holdings' Total Current Liabilities surged by 16137202.74% in 2021 and then crashed by 5923.82% in 2023.
  • Over the past 5 years, GeneDx Holdings' Total Current Liabilities (Quarter) stood at $101.3 million in 2021, then skyrocketed by 42.47% to $144.3 million in 2022, then crashed by 59.24% to $58.8 million in 2023, then fell by 6.8% to $54.8 million in 2024, then skyrocketed by 59.84% to $87.6 million in 2025.
  • Its Total Current Liabilities was $87.6 million in Q3 2025, compared to $71.4 million in Q2 2025 and $69.5 million in Q1 2025.